BioDelivery Sciences International (FRA:BD5) Net Change in Cash : €2.7 Mil (TTM As of Dec. 2021)

View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

BioDelivery Sciences International's Net Change in Cash for the three months ended in Dec. 2021 was €12.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2021 was €2.7 Mil.

BioDelivery Sciences International Net Change in Cash Historical Data

The historical data trend for BioDelivery Sciences International's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Net Change in Cash Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Net Change in Cash

Get a 7-Day Free Trial

-9.15

19.89

18.06

39.21

2.41

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Net Change in Cash	Get a 7-Day Free Trial															9.39	4.08	2.84	-16.27	12.04

BioDelivery Sciences International Net Change in Cash Calculation

BioDelivery Sciences International's Net Change in Cash for the fiscal year that ended in Dec. 2021 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	36.318	+	-6.082	+	-27.824	+	0
	=	2.4

BioDelivery Sciences International's Net Change in Cash for the quarter that ended in Dec. 2021

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 12.167 + -0.001 + -0.131 + 0

= 12.0

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International Net Change in Cash Related Terms
Thank you for viewing the detailed overview of BioDelivery Sciences International's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Net Change in Cash

Comparable Companies

SIGA VYGR BYSI PRTA ANIK RUBY DVAX BCEL IMRA XENE OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines